Evaluation of Ingenol Mebutate for Actinic Cheilitis Treatment

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Actinic cheilitis is a major potentially carcinogenic disorder of the lower lip and several reports of clinical cases with excellent results for the treatment of this lesion that can differentiate to squamous cell carcinoma of the lip. However, clinical trials are lacking to define the optimal dosage of the drug for a therapeutic modality and to define its true efficacy in controlled studies of this pre-malignant labial lesion.
Epistemonikos ID: 1d8323736edb0999a49417837042829064841f86
First added on: May 21, 2024